1 minute readJune 2, 20219:24 AM UTCLast Updated ago

Russia's Sputnik Light vaccine approved for use in Mauritius - RDIF

Vials labeled Sputnik V coronavirus disease (COVID-19) vaccine — Vials labeled "Sputnik V coronavirus disease (COVID-19) vaccine", March 24, 2021. REUTERS / Dado Ruvic/File Photo

MOSCOW, June 2 (Reuters) - Russia's single-dose Sputnik Light vaccine against COVID-19 has been approved for use in Mauritius, Russia's RDIF sovereign wealth fund, which markets the shot internationally, said on Wednesday.

Reporting by Alexander Marrow; Editing by Maria Kiselyova

Our Standards: The Thomson Reuters Trust Principles.

Business

Analysis: Outlook for European banks left clouded as storm abates, article with galleryFinancecategory · March 31, 2023
European banking stocks were meant to shine in 2023.
ChargedcategoryNikola tumbles to record low on $100 million stock sale, article with imageMarch 31, 2023
FinancecategorySwiss economists question UBS takeover of Credit Suisse in poll, article with imageMarch 31, 2023
BusinesscategoryPDVSA's supervising board to appeal new creditors' move to go after Citgo, article with imageMarch 31, 2023
ChargedcategoryStellantis' Portugal plant to produce large series fully battery electric compact vans, article with imageMarch 31, 2023

Russia's Sputnik Light vaccine approved for use in Mauritius - RDIF

Read Next

Business

Thomson Reuters Products

Refinitiv Products